About AmacaThera
AmacaThera is a company based in Toronto (Canada) founded in 2015. AmacaThera has raised $14.22 million across 3 funding rounds from investors including BDC, Viva BioInnovator and Lumira Ventures. AmacaThera operates in a competitive market with competitors including Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.22 M (USD)
in 3 rounds
-
Latest Funding Round
$8.16 M (USD), Series A
Feb 22, 2021
-
Investors
BDC
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of AmacaThera
Unlock access to complete
Unlock access to complete
Funding Insights of AmacaThera
AmacaThera has successfully raised a total of $14.22M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8.16 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AmacaThera
AmacaThera has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include BDC, Viva BioInnovator and Lumira Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Locked | Locked | Locked | |
|
Biotechnology startups are incubated and funded by Viva BioInnovator.
|
Locked | Locked | Locked | |
|
Online lottery results are provided for Hongkong players daily.
|
Locked | Locked | Locked |
Investor details for AmacaThera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AmacaThera
Investment portfolio details for AmacaThera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AmacaThera
Detailed financials for AmacaThera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amacathera Comparisons
Peer comparison for AmacaThera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AmacaThera
AmacaThera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| Locked | Locked | Locked |
Regentis Biomaterials is focused on tissue repair hydrogel technology.
|
|
| Locked | Locked | Locked |
Synthetic soft tissue substitutes for cosmetics and reconstructive surgery
|
|
| Locked | Locked | Locked |
Biotherapeutic thermogels are developed for tissue repair applications.
|
|
| Locked | Locked | Locked |
Diagnostic and therapeutic products from extracellular matrix are developed.
|
Detailed competitors of AmacaThera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amacathera
Complete news archive for AmacaThera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmacaThera
AmacaThera was founded in 2015 and raised its 1st funding round 4 years after it was founded.
AmacaThera is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
AmacaThera is a funded company, having raised a total of $14.22M across 3 funding rounds to date.
AmacaThera was founded in 2015 in Toronto, Canada, within the biotechnology sector. An injectable hydrogel platform is developed by the company for diverse medical uses, including the delivery of pharmacological agents to address multiple disease areas. Operations focus on therapeutic innovations, with a combination product created for managing post-operative pain. The platform supports applications in healthcare delivery across various indications.
AmacaThera's top competitors include Augmenix, LifeSprout and Regentis Biomaterials.
AmacaThera has 10 investors. Key investors include BDC, Viva BioInnovator, Lumira Ventures, HK Pools, and Inveready.